Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination–proficient ovarian cancer
Compadre, Amanda, Drexler, Rebecca, Loeb, Megan, Rodriguez, Kevin, Brill, Joshua, Harrington, Shariska P. , Sandoval, Carmen, Sanders, Brooke E. , Kuroki, Lindsay M. , Hagemann, Andrea R. , Powell, Matthew A. , Walts, Ann E. , Karlan, Beth, Oršulić, Sandra , Zhao, Peinan , Khabele, Dineo , Harrington, Shariska, Schab, Angela M. , Compadre, Amanda J. , Drexler, Rebecca, McCourt, Carolyn Kay , Thaker, Premal H. , Mutch, David G. , Serra, Violeta , Hagemann, Ian S. , Fuh, Katherine Cynthia , Sun, Lulu , Verma, Priyanka , Lomonosova, Elena , Mullen, Mary Margaret

Journal of Clinical Investigation | May 20, 2025 | Volume: 135 | Issue: 13 | Pages: No page available

10.1172/jci189511 | PMID 40392598 Get It

BACKGROUND Treatment of tubo-ovarian high-grade serous carcinoma (HGSC) includes cytoreductive surgery, platinum-based chemotherapy, and often poly(ADP-ribose) polymerase (PARP) inhibitors. While homologous recombination (HR) deficiency is a well-established predictor of therapy sensitivity, over 50% of HR-proficient HGSCs also exhibit sensitivity. Currently, there are no biomarkers to identify which HR-proficient HGSCs will be sensitive to standard-of-care therapy. Replication stress may serve as a key determinant of response. METHODS We evaluated phospho–RPA2-T21 (p-RPA2) foci via immunofluorescence as a biomarker of replication stress in formalin-fixed, paraffin-embedded HGSC samples collected at diagnosis from patients treated with platinum chemotherapy (discovery cohort, n = 31; validation cohort, n = 244) or PARP inhibitors ( n = 63). Recurrent HGSCs ( n = 38) were also analyzed. p-RPA2 score was calculated using automated imaging analysis. RESULTS Samples were defined as p-RPA2-high if more than 16% of cells had ≥2 p-RPA2 foci on automated analysis. In the discovery cohort, HR-proficient, p-RPA2-high HGSCs demonstrated significantly higher rates of a chemotherapy response score of 3 to platinum chemotherapy than HR-proficient, p-RPA2-low HGSCs. In the validation cohort, patients with HR-proficient, p-RPA2-high HGSCs had significantly longer survival after platinum treatment than those with HR-proficient, p-RPA2-low HGSCs. Additionally, the p-RPA2 assay effectively predicted survival outcomes in patients treated with PARP inhibitors and in recurrent HGSC samples. CONCLUSION Our study underscores the importance of considering replication stress markers, such as p-RPA2, alongside HR status in therapeutic planning. This approach has the potential to increase the number of patients receiving effective therapy while reducing unnecessary toxicity. FUNDING The Reproductive Scientist Development Program, GOG Foundation, Pilot Translational and Clinical Studies function of the Washington University Institute of Clinical and Translational Sciences, the Foundation for Barnes-Jewish Hospital, Washington University School of Medicine Dean’s Scholar Program, The Cancer Biology Pathway Training Grant (5T32CA113275-17), The Lucy, Anarcha, and Betsey (L.A.B.) Award from the Department of Obstetrics and Gynecology at Washington University School of Medicine, and Veterans Affairs Office of Research and Development (I01BX006020).
Correction: Activation of PI3K/Akt/mTOR signaling in the tumor stroma drives endocrine therapy-dependent breast tumor regression
Polo, María Laura, Riggio, Marina, May, María , Rodriguez, María Jimena , Perrone, María Cecilia , Kaen, Diego, Frost, Marlene H., Stallings-Mann, Melody, Frost, Marlene, Boughey, Judy, Radisky, Derek, Polo, María L. , Stallings‐Mann, Melody , Goetz, Matthew P. , Boughey, Judy C. , Lanari, Claudia , Radisky, Derek C. , Novaro, Virginia

Oncotarget | May 20, 2025 | Volume: 16 | Issue: 1 | Pages: 379-381

10.18632/oncotarget.28728 | PMID 40391748 Get It

Artificial Intelligence in Gastroenterology Education: DeepSeek Passes the Gastroenterology Board Examination and Outperforms Legacy ChatGPT Models
Ibrahim, Andrew , Danpanichkul, Pojsakorn , Hayek, Alberto , Paul, Elahna , Farag, Annmarie , Mansoor, Masab , Cheungpasitporn, Wisit , Othman, Mohamed O. , Ibrahim, Andrew F , Hayek, Alexander , Paul, Edwin , Cheungpasitporn, Wisit , Othman, Mohamed O , Danpanichkul, Pojsakorn , Thongprayoon, Charat

American Journal of Gastroenterology | May 20, 2025 | Volume: 121 | Issue: 4 | Pages: 1041-1043

10.14309/ajg.0000000000003552 | PMID 40392256 Get It

INTRODUCTION: DeepSeek was evaluated in gastroenterology board examination performance against legacy ChatGPT offline models, which previously showed failing performance. METHODS: The performances of the DeepSeek base R1 model and search-augmented R1 model were assessed using American College of Gastroenterology self-assessments (455 questions). RESULTS: DeepSeek exceeded the passing threshold. Search-augmented DeepSeek scored 81.5% across all questions, and the R1 base model scored 77.1%. Both search-augmented and offline DeepSeek models surpassed offline ChatGPT-3 (65.1%) and ChatGPT-4 (62.4%) ( P < 0.001). DISCUSSION: DeepSeek exhibited passing performance on the gastroenterology board examination but had gaps in niche topics and image exclusion limit utility. It may supplement education if validated by specialists.
Impact of Preoperative Povidone Nasal Swab on the Incidence of Surgical Site Infection: An Observational Study
Edwards, Michael A. , Caballero, Anyull D. Bohorquez, Glasgow, Amy E. , Whaley, Renee, Bosch, Wendelyn , Dahab, T , Spaulding, Aaron , Bohorquez Caballero, Anyull D, Glasgow, Amy, Dahab, Talal M, Spaulding, Aaron , Whaley, Renee, Colibaseanu, Dorin , Edwards, Michael

Journal of Patient Safety | May 20, 2025 | Volume: 21 | Issue: 5 | Pages: 348-355

10.1097/pts.0000000000001348 | PMID 40391879 Get It

Objectives: Surgical site infections (SSIs) are the most common hospital-acquired infections in the United States, of which methicillin-resistant Staphylococcus aureus (MRSA) accounts for 43%. Preoperative povidone-iodine nasal swab (PNS) is considered an effective and cost-saving treatment for Staphylococcus aureus decolonization. We aim to assess the impact of preoperative PNS on SSI incidence. Materials and Methods: This retrospective observational study utilized elective surgical cases between January 1, 2018 and May 31, 2023, at a single academic medical center. The cohort was divided into PNS and no PNS groups. The cohort was propensity-matched, and Pearson χ2/Kruskal-Wallis tests were performed to compare group differences. Multivariable logistic regression was utilized to compare events between cohorts before and after matching. An alpha of <0.05 was considered significant. Results: A total of 45,998 (22,999 per group) matched participants were evaluated. On multivariate regression, the non-PNS treatment group was associated with an increase in hospital overall SSI occurrence (OR: 1.48, P = 0.02) but not specifically in-hospital methicillin-sensitive Staphylococcus aureus SSI, MRSA-SSI, or any 30-day SSI (P > 0.05). Compared with PNS treatment and prophylactic antibiotics, in-hospital SSI was higher in the absence of PNS treatment (OR: 1.83, P < 0.001), antibiotic (OR: 2.63, P < 0.001), or both (OR: 2.06, P < 0.01). Compared with PNS treatment plus prophylactic antibiotic, in-hospital MRSA-SSI was only higher in the absence of antibiotic (OR: 2.92, P < 0.01) treatment. Conclusions: Preoperative treatment with PNS may reduce overall in-hospital SSI but has no independent impact on MRSA SSI.
The Oxygen Secretion Controversy
Roy, Deborah A., Roy, Tuhin K.

A&A Practice | May 20, 2025 | Volume: 19 | Issue: 5 | Pages: e01971

10.1213/xaa.0000000000001971 | PMID 40391821 Get It

Novel Benchmark for Robotic Liver Resection – Bridging Tradition with Innovation
Pfister, Matthias , Ma, Yong , Yang, Guangchao, Li, Linqiang , Song, Xuan , Venezia, Raphael, Jeddou, Heithem , Floc’h, Bastien Le, Valverde, A. , Péru, N. , Pessaux, Patrick, Salloum, Chady , Blanc, P., Scatton, Olivier , Tzedakis, Stylianos , Fuks, David , Chaoui, Ismaël, Silva, Silvia Gomes da, Sobral, M., Centonze, Leonardo , Zhu, Zhu , Ratti, Francesca, Rompianesi, Gianluca , Shah, Jimmy, Wakabayashi, Taiga , Coelho, Fabrício Ferreira , Castillo‐Flores, Samy , Viti, Virginia, Boggi, Ugo , Han, Ho-Seong, Panaro, Fabrizio , Wakabayashi, Go, Ielpo, Benedetto , Mejia, Alejandro , Troisi, Roberto I., Choi, Gi Hong , Liu, Rong , Sucandy, Iswanto, Rela, Mohamed , D’Hondt, Mathieu , Bröering, Dieter C. , Clavien, Pierre‐Alain , Li, Zhihao , Dong, Yawen , Clavien, Pierre-Alain , Centonze, Leonardo , Li, Zhihao , Li, Zhihao, Raptis, Dimitri , Song, Xuan, Millet, Guillaume, Truant, Stéphanie , Venezia, Raphael, Pessaux, Patrick , Giannone, Fabio , Mabrut, Jean‐Yves , Mohkam, Kayvan , Cunha, António Sá , Roy, Bertrand Le , Goumard, Claire , Fuks, David , Rammohan, Ashwin , Silva, Silvia Gomes da, López‐López, Víctor , Ratti, Francesca, Marino, Rebecca , Müller, Philip C , Lee, Bo Ram , Kato, Yutaro , Polanco, Patricio Marcelo , Goh, Brian K P , Cheung, Tan To , Efanov, Mikhail G. , Machado, Marcel Cerqueira César , Herman, Paulo , Müller-Stich, Beat Peter , Starlinger, Patrick , Martinie, John B. , Aldrighetti, Luca , Chen, Guodong , Robles, R , Benedetto, Fabrizio Di , Marques, Hugo P. , Sucandy, Iswanto , Brustia, Raffaele , Soubrane, Olivier

Annals of Surgery | May 20, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/sla.0000000000006759 | PMID 40391433 Get It

Objective: To establish benchmark cutoffs for robotic liver resection (R-LR), encompassing both major and minor resections, and to determine the impact of patient selection on outcomes. Background: R-LR is a key advancement in minimally invasive liver surgery but lacks standardized benchmarks, especially for minor resections. While guidelines endorse R-LR, its role in optimizing outcomes remains unclear. This study establishes the first benchmarks for R-LR, enabling comparisons across surgical modalities and refining patient selection. Methods: This retrospective, multicenter study analyzed consecutive adult patients undergoing R-LR at 30 international centers (2020–2023). Benchmark centers had an annual case volume of ≥15 R-LR. Benchmark criteria included ASA ≤2, no major comorbidities, no prior liver resections, and Child-Pugh A status. Benchmark cutoffs for 14 key outcomes were set at the 50th and 75th percentiles of median values across benchmark centers. Multivariable logistic regression identified predictors of textbook outcomes. Results: Eighteen high-volume centers contributed 4028 cases with 2632 (65.3%) meeting benchmark criteria. Malignancy was the indication in 29.6%, most commonly hepatocellular carcinoma followed by colorectal liver metastases. Major liver resection was performed in 42.6%. The distribution of Iwate difficulty scores was low (25.4%), intermediate (53.9%), advanced (15.9%), and expert (4.9%). Benchmark cutoffs were established for minor and major resection, and stratified by Iwate low (0-3), intermediate (4-6) and high (7-12): Open conversion (≤6.5% minor, ≤10.5% major), major complications within 90 days (≤5.2% minor, ≤16.7% major), R1 resection (≤9.2% minor, ≤6.7% major). Benchmark cases performed at low-volume centers were able to achieve outcomes within the corresponding benchmark cutoffs. In fact, patient selection reflected by the proportion of benchmark patients, rather than case volume, was associated with textbook outcomes. Conclusions: This study defines R-LR benchmarks, emphasizing patient selection over center volume for optimal outcomes. Benchmark cutoffs guide training and support the expansion of R-LR.
Corrigendum to: UAE Consensus on Patient Profiles for Pre-exposure Prophylaxis with Monoclonal Antibodies against COVID-19 in Hematological Malignancies and Immunocompromised States
Hashmi, Shahrukh K. , Abdalla, Jehad , Alam, Arif, Abuhaleeqa, Mohamed , Mehiri, Amna Al, Lal, Amar , Osman, Hani, Kaloyannidis, Panayotis , George, Biju

New Emirates Medical Journal | May 20, 2025 | Volume: 05 | Issue: No issue available | Pages: No page available

10.2174/025068820501250516143704 Get It

The authors requested to update the acknowledgement, funding, and authors contribution section in their article titled “UAE Consensus on Patient Profiles for Pre-exposure Prophylaxis with Monoclonal Antibodies against COVID-19 in Hematological Malignancies and Immunocompromised States” published in “New Emirates Medical Journal,” 2024; 5: e02506882347591 [1]. We apologize for any inconvenience caused and appreciate the opportunity to rectify this matter. The original article can be found online at https://www. eurekaselect.com/article/147185 Original: AUTHORS’ CONTRIBUTIONS It is hereby acknowledged that all authors have accepted responsibility for the manuscript's content and consented to its submission. They have meticulously reviewed all results and unanimously approved the final version of the manuscript. FUNDING None. ACKNOWLEDGEMENTS Declared none. Corrected: AUTHORS’ CONTRIBUTIONS S.H., J.A., A.R.A., M.A., A.Al.M., B.G., A.L., H.Y.O., P.K.: All contributed to the delphie and discus-sion meetings; S.H., A.Al.M., A.R.A. and M.A.: Contributed to writing the main manuscript; S.H., B.G., A.L., H.Y.O., P.K.: Contributed to revising the main manuscript. FUNDING The consensus logistics and medical publication was funded by AstraZeneca FZ LLC, Dubai, United Arab Emirates. ACKNOWLEDGEMENTS The authors extend their sincere gratitude to Meeting Minds Medical Communications Agency for their unwavering support in medical content development, including invaluable editorial and formatting assis-tance, which significantly contributed to the successful completion of the manuscript. Additionally, we express our appreciation to the Emirates Society of Hematology (ESH) for their endorsement of this work, further enhancing its credibility and relevance within the field. A courtesy copy of the final manuscript was provided to AstraZeneca as a gesture of acknowledgment for their interest in this research endeavor.
Comparative Performance of Scribe and Database Search Engines in Metaproteomic Profiling of a Ground-Truth Microbiome Dataset
Rajczewski, Andrew T. , Mehta, Subina , Wagner, Reid , Gabriel, Wassim , Johnson, James E. , Do, Katherine , Vintila, Simina , Wilhelm, Mathias , Kleiner, Manuel , Searle, Brian C. , Griffin, Timothy J , Jagtap, Pratik D , Searle, Brian C , Griffin, Timothy J. , Jagtap, Pratik

No container title available | May 20, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1101/2025.05.15.654320 | PMID 40475569 Get It

ABSTRACT Mass spectrometry-based metaproteomics, the identification and quantification of thousands of proteins expressed by complex microbial communities, has become pivotal for unraveling functional interactions within microbiomes. However, metaproteomics data analysis encounters many challenges, including the search of tandem mass spectra against a protein sequence database using proteomics database search algorithms. We used a ground-truth dataset to assess a spectral library searching method against established database searching approaches. Mass spectrometry data collected by data-dependent acquisition (DDA-MS) was analyzed using database searching approaches (MaxQuant and FragPipe), as well as using Scribe with Prosit predicted spectral libraries. We used FASTA databases that included protein sequences from microbial species present in the ground-truth dataset along with background protein sequences, to estimate error rates and assess the effects on detection, peptide-spectral match quality, and quantification. Using the Scribe search engine resulted in more proteins detected at a 1% false discovery rate (FDR) compared to MaxQuant or FragPipe, while FragPipe detected more peptides verified by PepQuery. Scribe was able to detect more low-abundance proteins in the microbiome dataset and was more accurate in quantifying the microbial community composition. This research provides insights and guidance for metaproteomics researchers aiming to optimize results in their analysis of DDA-MS data.
Associations between neck circumference, obstructive sleep apnea, and arterial stiffness in older adults
Brutto, Óscar H. Del , Mera, Robertino M. , Costa, Aldo F. , Rumbea, Denisse A. , Arias, Emilio E. , Brutto, Víctor J. Del , Del Brutto, Oscar H , Del Brutto, Victor J , Rumbea, Denisse A , Castillo, Pablo R.

Vascular Medicine | May 20, 2025 | Volume: 30 | Issue: 4 | Pages: 482-484

10.1177/1358863x251334144 | PMID 40391654 Get It

Artificial Intelligence and Musculoskeletal Surgical Applications
Oettl, Felix C. , Oeding, Jacob F. , Oeding, Jacob F , Oettl, Felix C. , Zsidai, Bálint , Samuelsson, Kristian

HSS Journal®: The Musculoskeletal Journal of Hospital for Special Surgery | May 20, 2025 | Volume: 21 | Issue: 3 | Pages: 267-273

10.1177/15563316251339596 | PMID 40405922 Get It

Artificial intelligence (AI) has emerged as a transformative force in orthopedic surgery. Potentially encompassing pre-, intra-, and postoperative processes, it can process complex medical imaging, provide real-time surgical guidance, and analyze large datasets for outcome prediction and optimization. AI has shown improvements in surgical precision, efficiency, and patient outcomes across orthopedic subspecialties, and large language models and agentic AI systems are expanding AI utility beyond surgical applications into areas such as clinical documentation, patient education, and autonomous decision support. The successful implementation of AI in orthopedic surgery requires careful attention to validation, regulatory compliance, and healthcare system integration. As these technologies continue to advance, maintaining the balance between innovation and patient safety remains crucial, with the ultimate goal of achieving more personalized, efficient, and equitable healthcare delivery while preserving the essential role of human clinical judgment. This review examines the current landscape and future trajectory of AI applications in orthopedic surgery, highlighting both technological advances and their clinical impact. Studies have suggested that AI-assisted procedures achieve higher accuracy and better functional outcomes compared to conventional methods, while reducing operative times and complications. However, these technologies are designed to augment rather than replace clinical expertise, serving as sophisticated tools to enhance surgeons’ capabilities and improve patient care.